A transgenic mouse line expressing a truncated form of the
ornithine decarboxylase (ODC) dominant-negative mutant K69A/C360A under the control of the
keratin 6 promoter has been established (K6/ODCdn mice). These mice were backcrossed onto both the DBA/2J and C57BL/6J backgrounds for subsequent
tumorigenesis experiments utilizing an initiation/promotion protocol. In short-term experiments, expression of the ODCdn
protein product was induced in the epidermis within 24 h after application of the
tumor promoter tetradecanoyl
phorbol acetate (TPA) to the skin, and ODC activity in the epidermis of K6/ODCdn mice was reduced by at least 75% compared with littermate controls. However, in
tumorigenesis experiments utilizing a variety of initiator (7,12-dimethylbenz[a]
anthracene; DMBA) and promoter (TPA) concentrations, K6/ODCdn mice formed at least as many
tumors as their littermate controls regardless of background strain. In experiments utilizing
chrysarobin, a
tumor promoter with a different mechanism of action than TPA, again there was no significant difference in
tumor formation between K6/ODCdn mice and littermate controls. Similarly, when K6/ODCdn mice were crossed with K5/ODC mice, a transgenic line described previously which forms
tumors without application of a promoting agent, double transgenic mice formed as many
tumors as mice expressing the K5/ODC transgene alone. Analysis of epidermis following multiple TPA applications revealed a dramatic spike in ODC activity in both K6/ODCdn mice and non-transgenic mice after six applications, and western blot analysis suggested a stabilization of endogenous wild-type ODC in K6/ODCdn transgenic mice. ODC activity, endogenous
protein and
polyamines were also elevated in
tumors from K6/ODCdn mice. The accumulation of endogenous ODC
protein is most probably the result of competition from the transgene-derived ODCdn
protein for binding of antizyme, which is known to regulate ODC activity by stimulating degradation of the ODC
protein.